GlassScriptPhysician profile
Paul E Sullivan
NPI 1417953647
$7,017.12
in general payments reported to CMS, 2019-2025
14 companies · $2,992 in 2025
The $2,992 reported for 2025 was more than what 97% of Foot Surgery providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $399 · 2020: $81.17 · 2021: $188 · 2022: $484 · 2023: $420 · 2024: $2,454 · 2025: $2,992.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,100 · Food and Beverage: $1,766.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,100.00 |
| Food and Beverage | $1,765.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trice Medical, INC. | $4,528.70 | 2024-2025 | |
| Bioventus LLC | $1,218.57 | 2019-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Kuros Biosciences USA, INC | $179.13 | 2025 | Magnetos |
| Tenex Health INC. | $177.40 | 2019 | |
| Smith+Nephew, INC. | $167.34 | 2022 | |
| Alafair Biosciences, INC. | $166.83 | 2024 | Versawrap |
| Extremity Medical | $158.56 | 2023 | Io Fix |
| Paragon 28, INC. | $114.97 | 2025 | Trauma |
| Horizon Therapeutics Plc | $107.26 | 2019-2021 | |
| Linvatec Corporation | $91.14 | 2023 | Colink 2, Allograft Tissue, Fracture and Correction Colag 2 |
| Depuy Synthes Sales INC. | $61.53 | 2019-2023 | Monovisc |
| Pfizer INC. | $26.49 | 2019-2020 | |
| Orthofix Medical, INC. | $19.20 | 2025 | Physio-Stim |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Sullivan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.